Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
Clinical trial NCT03478488 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03478488
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2024-09-10
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.